Is the Fed Put Back in Play, and What’s Next for Biogen? 9/28/22 episode artwork

EPISODE · Sep 28, 2022 · 43 MIN

Is the Fed Put Back in Play, and What’s Next for Biogen? 9/28/22

from CNBC's "Fast Money" · host CNBC

Stocks rallying after hitting the year’s lows as one central bank indicated it’s willing to step in to calm the markets. But will the Fed follow suit or is there more turmoil ahead? Plus Biogen making a major breakthrough with its Alzheimer’s treatment. What it means for the stock and the rest of the biotech space. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode metadata supplied by the publisher feed · Published Sep 28, 2022

Embed this episode

Stocks rallying after hitting the year’s lows as one central bank indicated it’s willing to step in to calm the markets. But will the Fed follow suit or is there more turmoil ahead? Plus Biogen making a major breakthrough with its Alzheimer’s treatment. What it means for the stock and the rest of the biotech space.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Is the Fed Put Back in Play, and What’s Next for Biogen? 9/28/22

0:00 43:56

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of CNBC's "Fast Money"?

This episode is 43 minutes long.

When was this CNBC's "Fast Money" episode published?

This episode was published on September 28, 2022.

Can I download this CNBC's "Fast Money" episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!